S&P 500   4,971.90 (-0.78%)
DOW   37,855.71 (+0.21%)
QQQ   417.33 (-1.44%)
AAPL   164.64 (-1.44%)
MSFT   400.51 (-0.93%)
META   484.41 (-3.47%)
GOOGL   154.09 (-1.23%)
AMZN   175.53 (-2.06%)
TSLA   149.51 (-0.28%)
NVDA   811.76 (-4.13%)
AMD   148.70 (-4.11%)
NIO   3.84 (-4.00%)
BABA   68.63 (-0.36%)
T   16.34 (+0.06%)
F   12.11 (+0.41%)
MU   107.36 (-4.08%)
GE   149.14 (-2.48%)
CGC   7.98 (+1.92%)
DIS   111.55 (-0.78%)
AMC   3.24 (+10.96%)
PFE   25.85 (+1.81%)
PYPL   62.03 (-0.11%)
XOM   120.11 (+1.34%)
S&P 500   4,971.90 (-0.78%)
DOW   37,855.71 (+0.21%)
QQQ   417.33 (-1.44%)
AAPL   164.64 (-1.44%)
MSFT   400.51 (-0.93%)
META   484.41 (-3.47%)
GOOGL   154.09 (-1.23%)
AMZN   175.53 (-2.06%)
TSLA   149.51 (-0.28%)
NVDA   811.76 (-4.13%)
AMD   148.70 (-4.11%)
NIO   3.84 (-4.00%)
BABA   68.63 (-0.36%)
T   16.34 (+0.06%)
F   12.11 (+0.41%)
MU   107.36 (-4.08%)
GE   149.14 (-2.48%)
CGC   7.98 (+1.92%)
DIS   111.55 (-0.78%)
AMC   3.24 (+10.96%)
PFE   25.85 (+1.81%)
PYPL   62.03 (-0.11%)
XOM   120.11 (+1.34%)
S&P 500   4,971.90 (-0.78%)
DOW   37,855.71 (+0.21%)
QQQ   417.33 (-1.44%)
AAPL   164.64 (-1.44%)
MSFT   400.51 (-0.93%)
META   484.41 (-3.47%)
GOOGL   154.09 (-1.23%)
AMZN   175.53 (-2.06%)
TSLA   149.51 (-0.28%)
NVDA   811.76 (-4.13%)
AMD   148.70 (-4.11%)
NIO   3.84 (-4.00%)
BABA   68.63 (-0.36%)
T   16.34 (+0.06%)
F   12.11 (+0.41%)
MU   107.36 (-4.08%)
GE   149.14 (-2.48%)
CGC   7.98 (+1.92%)
DIS   111.55 (-0.78%)
AMC   3.24 (+10.96%)
PFE   25.85 (+1.81%)
PYPL   62.03 (-0.11%)
XOM   120.11 (+1.34%)
S&P 500   4,971.90 (-0.78%)
DOW   37,855.71 (+0.21%)
QQQ   417.33 (-1.44%)
AAPL   164.64 (-1.44%)
MSFT   400.51 (-0.93%)
META   484.41 (-3.47%)
GOOGL   154.09 (-1.23%)
AMZN   175.53 (-2.06%)
TSLA   149.51 (-0.28%)
NVDA   811.76 (-4.13%)
AMD   148.70 (-4.11%)
NIO   3.84 (-4.00%)
BABA   68.63 (-0.36%)
T   16.34 (+0.06%)
F   12.11 (+0.41%)
MU   107.36 (-4.08%)
GE   149.14 (-2.48%)
CGC   7.98 (+1.92%)
DIS   111.55 (-0.78%)
AMC   3.24 (+10.96%)
PFE   25.85 (+1.81%)
PYPL   62.03 (-0.11%)
XOM   120.11 (+1.34%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
$11.01
+0.2%
$10.92
$10.36
$11.40
$171.76M-0.0140,200 shs25,782 shs
Meredith Co. stock logo
MDP
Meredith
$58.78
$18.00
$59.16
$2.70B2.07552,848 shs3.36 million shs
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
C$0.00
C$0.03
C$0.64
N/AN/A79,508 shs287,225 shs
Zomedica Corp. stock logo
ZOM
Zomedica
$0.13
-1.1%
$0.00
$0.12
$0.25
$125.34M15.20 million shs1.46 million shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
0.00%0.00%+0.23%+1.48%+4.97%
Meredith Co. stock logo
MDP
Meredith
0.00%0.00%0.00%0.00%-16.22%
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
0.00%0.00%0.00%0.00%0.00%
Zomedica Corp. stock logo
ZOM
Zomedica
0.00%0.00%+1.67%+4.23%-33.73%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Meredith Co. stock logo
MDP
Meredith
N/AN/AN/AN/AN/AN/AN/AN/A
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/AN/AN/AN/AN/AN/AN/A
Zomedica Corp. stock logo
ZOM
Zomedica
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
3.00
Buy$12.5013.53% Upside
Meredith Co. stock logo
MDP
Meredith
N/AN/AN/AN/A
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/AN/AN/A
Zomedica Corp. stock logo
ZOM
Zomedica
N/AN/AN/AN/A

Current Analyst Ratings

Latest MMJ, ZOM, EVE, and MDP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/21/2024
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$13.50 ➝ $12.50
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
N/AN/AN/AN/AN/AN/A
Meredith Co. stock logo
MDP
Meredith
$2.98B0.00N/A5.68$14.27 per share0.00
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/AN/AN/AN/AN/A
Zomedica Corp. stock logo
ZOM
Zomedica
$25.19M4.98N/AN/A$0.24 per share0.53

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Meredith Co. stock logo
MDP
Meredith
$306.60M$5.9010.01N/AN/A9.66%41.72%4.92%N/A
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Zomedica Corp. stock logo
ZOM
Zomedica
-$34.53M-$0.04N/AN/A-137.10%-8.13%-7.68%5/9/2024 (Estimated)

Latest MMJ, ZOM, EVE, and MDP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/1/2024Q4 2023
Zomedica Corp. stock logo
ZOM
Zomedica
N/A-$0.01-$0.01N/A$7.00 million$7.34 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
N/AN/AN/AN/AN/A
Meredith Co. stock logo
MDP
Meredith
N/AN/AN/AN/AN/A
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/AN/AN/AN/A
Zomedica Corp. stock logo
ZOM
Zomedica
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
N/AN/AN/A
Meredith Co. stock logo
MDP
Meredith
4.03
1.39
1.36
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/AN/A
Zomedica Corp. stock logo
ZOM
Zomedica
N/A
11.06
10.49

Ownership

Institutional Ownership

CompanyInstitutional Ownership
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
N/A
Meredith Co. stock logo
MDP
Meredith
78.23%
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/A
Zomedica Corp. stock logo
ZOM
Zomedica
8.95%

Insider Ownership

CompanyInsider Ownership
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
2.90%
Meredith Co. stock logo
MDP
Meredith
9.79%
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/A
Zomedica Corp. stock logo
ZOM
Zomedica
4.18%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
N/A15.60 million15.15 millionNot Optionable
Meredith Co. stock logo
MDP
Meredith
5,33045.78 million41.30 millionOptionable
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/AN/ANot Optionable
Zomedica Corp. stock logo
ZOM
Zomedica
144979.95 million938.99 millionNot Optionable

MMJ, ZOM, EVE, and MDP Headlines

SourceHeadline
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
accesswire.com - April 9 at 6:30 AM
Zomedica Corp. (AMEX:ZOM) Q4 2023 Earnings Call TranscriptZomedica Corp. (AMEX:ZOM) Q4 2023 Earnings Call Transcript
msn.com - April 2 at 4:06 PM
Q4 2023 Zomedica Corp Earnings CallQ4 2023 Zomedica Corp Earnings Call
finance.yahoo.com - April 2 at 8:30 AM
ZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023ZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023
investorplace.com - April 1 at 9:06 PM
Zomedica reports Q4 resultsZomedica reports Q4 results
msn.com - April 1 at 5:27 PM
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in LiquidityZomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
accesswire.com - April 1 at 4:05 PM
The Next Millionaire-Makers: 3 Penny Stocks With Massive Upside PotentialThe Next Millionaire-Makers: 3 Penny Stocks With Massive Upside Potential
investorplace.com - April 1 at 3:12 PM
Zomedica to Report Fourth Quarter and Full Year 20…Zomedica to Report Fourth Quarter and Full Year 20…
pharmiweb.com - March 20 at 9:17 AM
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ETZomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
accesswire.com - March 20 at 6:30 AM
Zomedica Pharmaceuticals Corp (ZOM)Zomedica Pharmaceuticals Corp (ZOM)
investing.com - March 15 at 7:52 AM
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) PlatformZomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
accesswire.com - March 14 at 6:30 AM
Zomedica Provides NYSE American Listing UpdateZomedica Provides NYSE American Listing Update
accesswire.com - March 13 at 4:45 PM
Sidoti & Company, LLC: Sidoti Events, LLCs Virtual March Small-Cap ConferenceSidoti & Company, LLC: Sidoti Events, LLC's Virtual March Small-Cap Conference
finanznachrichten.de - March 12 at 11:26 AM
Zomedica Corp.: Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary ConferencesZomedica Corp.: Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences
finanznachrichten.de - March 12 at 8:22 AM
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary ConferencesZomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences
accesswire.com - March 12 at 6:30 AM
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working DogsZomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs
accesswire.com - March 7 at 6:30 AM
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024
accesswire.com - March 5 at 6:30 AM
Zomedica Pharmaceuticals Corp. (ZOM)Zomedica Pharmaceuticals Corp. (ZOM)
uk.finance.yahoo.com - March 1 at 2:46 PM
Zomedica Corp.: Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health ConferencesZomedica Corp.: Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences
finanznachrichten.de - February 8 at 9:14 AM
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health ConferencesZomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences
finance.yahoo.com - February 8 at 9:14 AM
Zomedica Corp.: Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share ConsolidationZomedica Corp.: Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation
finanznachrichten.de - February 6 at 5:00 PM
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)
finance.yahoo.com - February 6 at 5:00 PM
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ETZomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET
finance.yahoo.com - February 6 at 7:00 AM
Zomedica Corp. (ZOM) Interactive Stock Chart - Yahoo FinanceZomedica Corp. (ZOM) Interactive Stock Chart - Yahoo Finance
finance.yahoo.com - February 4 at 8:05 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

EVe Mobility Acquisition logo

EVe Mobility Acquisition

NYSE:EVE
EVe Mobility Acquisition Corp does not have significant operations. The company focuses on effectuating a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on the automotive and mobility industry. The company was incorporated in 2021 and is based in Wilmington, Delaware.
Meredith logo

Meredith

NYSE:MDP
Meredith Corp. engages in television broadcasting and magazine advertising business. It operates through the Local Media and National Media business segments. The Local Media segment includes television stations and offers websites, mobile-optimized websites, and mobile applications. The National Media segment consists of national consumer media brands delivered via multiple media platforms including print magazines and digital and mobile media, brand licensing activities, database-related activities, and business-to-business marketing products and services. The company was founded by Edwin Thomas Meredith in 1902 and is headquartered in Des Moines, IA.
Matica Enterprises logo

Matica Enterprises

CNSX:MMJ
Matica Enterprises Inc. focuses on medical marijuana business. It also holds interest in the Grumpy Lizard project in Nevada, the United States; and an option agreement to acquire a 100% interest in the Buckingham North property, a graphite project located east of Ottawa/Gatineau. The company was formerly known as Matica Graphite Inc. and changed its name to Matica Enterprises Inc. in July 2014. Matica Enterprises Inc. is headquartered in Toronto, Canada.
Zomedica logo

Zomedica

NYSEAMERICAN:ZOM
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.